Literature DB >> 2556011

Aggressive insulinoma with bone metastases.

C S Hesdorffer1, M Stoopler, J Javitch.   

Abstract

This is the first report of the development of bone metastases in a patient with an insulinoma. Following the development of bone metastases, further chemotherapy with etoposide (VP-16) and cis-platinum was not successful and the patient's condition was rapidly fatal. This case demonstrates the unusually aggressive course and poor response to currently available chemotherapeutic agents of a malignant insulinoma. The clinical and diagnostic features of insulinomas are reviewed.

Entities:  

Mesh：

Year:  1989        PMID： 2556011     DOI： 10.1097/00000421-198912000-00008

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN： 0277-3732            Impact factor:   2.339


  4 in total

1.  Malignant metastatic insulinoma-postoperative treatment and follow-up.

Authors:  Achim Starke; Christiane Saddig; Lothar Mansfeld; Rainer Koester; Cyrus Tschahargane; Peter Czygan; Peter Goretzki
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

Review 2.  Malignant insulinoma: spectrum of unusual clinical features.

Authors:  Boaz Hirshberg; Craig Cochran; Monica C Skarulis; Steven K Libutti; H Richard Alexander; Bradford J Wood; Richard Chang; David E Kleiner; Phillip Gorden
Journal:  Cancer       Date:  2005-07-15       Impact factor: 6.860

3.  Insulinoma.

Authors:  Andrew R Burns; Alan P B Dackiw
Journal:  Curr Treat Options Oncol       Date:  2003-08

4.  Malignant Insulinoma with Multiple Liver Metastases and Hypercalcitoninemia in a Patient with Type 2 Diabetes Mellitus Presenting as Recurrent Episodes of Diaphoresis due to Severe Hypoglycemia.

Authors:  Marco Ciacciarelli; Gianluca Caruso; Marco Rengo; Piero Maceroni; Carmen Misurale; Eleonora D'Armiento; Alessandro Polidoro; Cristina Napoli; Alberto Lombardini; Umberto Ceratti; Ruben Manuel Luciano Colunga Biancatelli; Leonardo Calvosa; Romina Milanese; Sonia Ferri; Teresa Massaro; Andrea Lorusso; Veronica Sorrentino; Vincenzo Petrozza; Luigi Iuliano
Journal:  Case Rep Endocrinol       Date:  2020-01-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.